{"entity":{"id":"mabion","kind":"company","name":"Mabion","aka":["Mabion SA","Mabion S.A."],"tldr":"Mabion is a Polish biotech near Łódź that developed a rituximab biosimilar, MabionCD20, through phase 3 trials in lymphoma and rheumatoid arthritis, and now also manufactures biologics for partners.","summary":"Mabion S.A., based in Konstantynów Łódzki and listed in Warsaw, built a biologics plant to develop and make biosimilar antibodies. Its rituximab biosimilar MabionCD20 was taken through phase 3 comparative trials in diffuse large B-cell lymphoma and rheumatoid arthritis, registered on ClinicalTrials.gov under Mabion as lead sponsor, and the company now also offers contract manufacturing.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://www.mabion.eu"},{"label":"ClinicalTrials.gov: trials led by Mabion SA","url":"https://clinicaltrials.gov/search?lead=Mabion%20SA"},{"label":"Wikidata","url":"https://www.wikidata.org/wiki/Q19653276"}],"tags":["ctgov-sponsor"],"related":[],"cancers":["dlbcl"],"sections":[],"technologies":[],"targets":[],"drugs":["rituximab"],"companies":[],"institutions":[],"pathways":[],"terms":["pivotal-trial","clinical-trial","biosimilar"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Konstantynów Łódzki","country":"PL","companyType":"biotech","website":"https://www.mabion.eu","stage":"public","investors":[],"funding":[]},"route":"/companies/mabion/","neighbours":{"cancer":[{"id":"dlbcl","kind":"cancer","name":"Diffuse large B-cell lymphoma","route":"/cancers/dlbcl/"}],"drug":[{"id":"rituximab","kind":"drug","name":"Rituximab","route":"/drugs/rituximab/"}],"term":[{"id":"biosimilar","kind":"term","name":"Biosimilar","route":"/terms/biosimilar/"},{"id":"clinical-trial","kind":"term","name":"Clinical trial","route":"/terms/clinical-trial/"},{"id":"pivotal-trial","kind":"term","name":"Pivotal (registrational) trial","route":"/terms/pivotal-trial/"}]}}